Get started
CCC

CLAL BIOTECH

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

CBI chart


Full chart

Key stats


Market capitalization
‪55.21 M‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.5 ILS
Net income (FY)
‪−31.05 M‬ ILS
Revenue (FY)
‪595.00 K‬ ILS
Shares float
‪55.54 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
100
Change (1Y)
−46 −31.51%
Revenue / Employee (1Y)
‪1.64 K‬ ILS
Net income / Employee (1Y)
‪−85.52 K‬ ILS

About CLAL BIOTECH


Sector
Finance
Industry
Financial Conglomerates
CEO
Assaf Segal
Website
cbi.co.il
Headquarters
Tel Aviv
Founded
1993
ISIN
IL0011042806
FIGI
BBG000QSGR48
Clal Biotechnology Industries Ltd. is a holding company which, engages in life sciences and medical technology research and development. It focuses on identifying and supporting innovative ventures, developing proprietary solutions, and addressing unmet medical needs. The company was founded on December 22, 1993 and is headquartered in Tel Aviv, Israel.

Financials


Performance
Revenue to profit conversion
Earnings
Next:—
‪0.00‬

CBI news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CBI is 36.4 ILA — it has decreased by −0.28% in the past 24 hours. Watch CLAL BIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange CLAL BIOTECH stocks are traded under the ticker CBI.
CBI stock has fallen by −3.84% compared to the previous week, the month change is a −12.90% fall, over the last year CLAL BIOTECH has showed a −19.11% decrease.
CBI reached its all-time high on Mar 7, 2010 with the price of 2,428.3 ILA, and its all-time low was 29.0 ILA and was reached on Jul 3, 2024. View more price dynamics on CBI chart.
See other stocks reaching their highest and lowest prices.
CBI stock is 4.00% volatile and has beta coefficient of 0.62. Track CLAL BIOTECH stock price on the chart and check out the list of the most volatile stocks — is CLAL BIOTECH there?
Today CLAL BIOTECH has the market capitalization of ‪55.21 M‬, it has increased by 0.57% over the last week.
Yes, you can track CLAL BIOTECH financials in yearly and quarterly reports right on TradingView.
CBI net income for the last half-year is ‪−41.26 M‬ ILS, while the previous report showed ‪−33.48 M‬ ILS of net income which accounts for −23.26% change. Track more CLAL BIOTECH financial stats to get the full picture.
As of Nov 21, 2024, the company has 100.00 employees. See our rating of the largest employees — is CLAL BIOTECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CLAL BIOTECH EBITDA is ‪−41.59 M‬ ILS, and current EBITDA margin is ‪−7.74 K‬%. See more stats in CLAL BIOTECH financial statements.
Like other stocks, CBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLAL BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLAL BIOTECH technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLAL BIOTECH stock shows the sell signal. See more of CLAL BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.